Related Experiment Video

Updated: Jul 17, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.8K

Defining a Childhood Type 1 Diabetes Cohort, Clinical Practice Measures, and Outcomes Within Administrative Data in

Danya Fox1, Qian Zhang2, Nazrul Islam3

  • 1Division of Endocrinology, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.

Canadian Journal of Diabetes
|August 31, 2023
PubMed

Insights

Researchers created a cohort of nearly 6,000 individuals with childhood-onset type 1 diabetes (T1D) using administrative data. This cohort enables studying T1D clinical practice measures and their impact on health outcomes.

Area of Science:

  • Endocrinology
  • Public Health
  • Data Science

Background:

  • Childhood-onset type 1 diabetes (T1D) requires long-term management and monitoring.
  • Administrative data offers a valuable resource for population-level health research.
  • Defining clinical practice measures is crucial for assessing diabetes care quality.

Purpose of the Study:

  • To establish a comprehensive administrative cohort of individuals with childhood-onset T1D in British Columbia.
  • To define key clinical practice measures relevant to T1D management using administrative data.

Main Methods:

  • Utilized linked administrative data from British Columbia spanning 1992-1993 to 2019-2020.
  • Applied a validated diabetes case-finding definition and differentiating algorithm to identify eligible individuals.
  • Defined clinical practice measures based on established clinical practice guidelines.

Main Results:

  • An administrative cohort of 5,901 individuals with childhood-diagnosed T1D was established (April 1, 1996 - March 31, 2020).
  • The cohort has a mean age of 22.31 years (SD 8.21).
  • Key derived clinical practice measures include outpatient visits, HbA1c tests, and screenings for thyroid, retinopathy, and nephropathy.

Conclusions:

  • An administrative cohort of approximately 6,000 individuals with childhood-onset T1D and over 20 years of follow-up data has been successfully created.
  • This cohort provides a robust foundation for future research on the relationship between clinical practice measures and clinical outcomes in T1D.
Abstract

Keywords:
administrative health datachildhood diabetesdiabète de l’enfantdonnées administratives sur la santémesures des résultatsoutcome measures

More Related Videos

Electrochemiluminescence Assays for Human Islet Autoantibodies09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

15.5K
Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.9K

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
588
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
986
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
147
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
205